Answers are grounded in this paper and cite their sources.
Administration of undiluted famotidine IV push shows no significant hemodynamic adverse effects in critically ill pediatric patients, suggesting safety for use.
Famotidine administered undiluted IVP produced no clinically significant hemodynamic -adverse effects in critically ill pediatric patients.
No takes yet. Share an insight, caveat, or question.
Caballero et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: